The Phase 3 trial will be conducted under the auspices of the first Regenerative Medicine Advanced Therapy (RMAT) designation approved by the USFDA for an EV therapeutic
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey
A staggering 65% of the TB cases in India are in the 15-45 age group
Submissions for Ruminant Well-Being Awards and Gustav Rosenberger Memorial Fund grant open now
MTBVAC is a global public-private project that will be a milestone in the field of vaccinology
Ritonavir oral tablet is a pharmacokinetic booster of multiple oral antiviral drugs targeting viral proteases and a component of the approved oral antiviral drug Paxlovid (Nirmatrelvir 300 mg tablet + ritonavir 100 mg tablet co-administration package)
Brazil has the 4th largest pet market in the world with an estimated market size of BRL 1.8 billion, growing annually at 16%
Collaboration aims to evolve precision medicine with cell-specific delivery of gene therapy
First Positive Study for KEYTRUDA in Adjuvant Stage IB-IIIA NSCLC
CuraTeQ and Orion had entered into a licensing agreement, granting marketing and distribution rights for CuraTeQ’s biosimilar products under development in the Nordic states, Austria, Hungary and Slovenia
Subscribe To Our Newsletter & Stay Updated
